You are here
Buz Investors NetworkNewsWire Announces Publication NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals Market News 

$IMLFF Announces Publication of Discussion on the R&D of Cannabinoids

NetworkNewsWire Announces Publication of Discussion on the R&D of Cannabinoids for Medical Use Buz Investors NetworkNewsWire Announces PublicationNetworkNewsWire (“NNW”), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF), an NNW client that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. The publication, entitled, “Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth,” discusses the rampant growth of the cannabis market and how a number of biotech companies…

Read More
Buz Investors InMed Pharmaceuticals ("InMed") (CSE: IN; OTCQB: IMLFF) announces today that Eric A. Adams, Chief Executive Officer, will be presenting to U.S. institutional investors at the 29th Annual ROTH Conference, Market News 

$IMLFF to Present at the 29th Annual ROTH Conference

InMed Pharmaceuticals to Present at the 29th Annual ROTH Conference Buz Investors InMed Pharmaceuticals  (“InMed”) (CSE: IN; OTCQB: IMLFF) announces today that Eric A. Adams, Chief Executive Officer, will be presenting to U.S. institutional investors at the 29th Annual ROTH Conference, which is being held March 12-15, 2017, at the Ritz Carlton, Laguna Niguel, California. “The ROTH Conference is one of the largest in the nation, and it does a wonderful job introducing small and mid-cap companies to institutional investors who are focused on these emerging opportunities,” said Chris Bogart,…

Read More